NAV: 28 Jul 2023 | ₹20.26 |
Min. SIP amount | Not Supported |
Rating | NA |
Fund size | ₹75.05Cr |
6M | 1Y | 3Y | All | |
---|---|---|---|---|
Fund returns | NA | 13.6% | 13.7% | 17.3% |
Category average | NA | 40.4% | 19.8% | NA |
Rank with in category | NA | 4 | 8 | NA |
Name | Sector | Instrument | Assets |
---|---|---|---|
Sun Pharmaceutical Industries Ltd. | Healthcare | Equity | 16.03% |
Divi's Laboratories Ltd. | Healthcare | Equity | 10.66% |
Cipla Ltd. | Healthcare | Equity | 8.90% |
Dr. Reddy's Laboratories Ltd. | Healthcare | Equity | 8.86% |
Apollo Hospitals Enterprise Ltd. | Healthcare | Equity | 8.64% |
JB Chemicals & Pharmaceuticals Ltd. | Healthcare | Equity | 6.54% |
Torrent Pharmaceuticals Ltd. | Healthcare | Equity | 5.48% |
Alkem Laboratories Ltd. | Healthcare | Equity | 4.21% |
Abbott India Ltd. | Healthcare | Equity | 4.08% |
Syngene International Ltd. | Healthcare | Equity | 3.73% |
Ipca Laboratories Ltd. | Healthcare | Equity | 3.44% |
Zydus Lifesciences Ltd. | Healthcare | Equity | 2.75% |
Aster DM Healthcare Ltd. | Healthcare | Equity | 2.62% |
Laurus Labs Ltd. | Healthcare | Equity | 2.40% |
Vinati Organics Ltd. | Chemicals | Equity | 2.26% |
Pfizer Ltd. | Healthcare | Equity | 1.82% |
Jubilant Ingrevia Ltd. | Chemicals | Equity | 1.70% |
Gland Pharma Ltd. | Healthcare | Equity | 1.33% |
Indoco Remedies Ltd. | Healthcare | Equity | 1.21% |
Natco Pharma Ltd. | Healthcare | Equity | 1.19% |
Inclusive of GST
Exit Load for units in excess of 12% of the investment,1% will be charged for redemption within 90 days.
0.005% (from July 1st, 2020)
Returns are taxed at 20%, if you redeem before one year. After 1 year, you are required to pay LTCG tax of 12.5% on returns of Rs 1.25 lakh+ in a financial year.
Min. for 1st investment | Not Supported |
Min. for 2nd investment onwards | Not Supported |
Min. for SIP | Not Supported |